China SXT Pharmaceuticals, Inc. (SXTC)
USD 2.49
(-0.8%)
USD 2.49
(-0.8%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 809.75 Thousand USD | 52.42% |
| 2023 | 531.25 Thousand USD | -47.79% |
| 2022 | 1.01 Million USD | 18.36% |
| 2021 | 859.69 Thousand USD | -3.7% |
| 2020 | 892.76 Thousand USD | -11.42% |
| 2019 | 1 Million USD | -20.44% |
| 2018 | 1.26 Million USD | 42.22% |
| 2017 | 890.78 Thousand USD | -48.16% |
| 2016 | 1.71 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q4 | 794.85 Thousand USD | -1.84% |
| 2024 Q2 | 581.31 Thousand USD | 0.0% |
| 2024 FY | 809.75 Thousand USD | 52.42% |
| 2024 Q3 | 809.75 Thousand USD | 39.3% |
| 2024 Q1 | 581.31 Thousand USD | 9.42% |
| 2023 FY | 531.25 Thousand USD | -47.79% |
| 2023 Q2 | 628.18 Thousand USD | -8.47% |
| 2023 Q3 | 577.55 Thousand USD | -8.06% |
| 2023 Q1 | 686.31 Thousand USD | -32.55% |
| 2023 Q4 | 531.25 Thousand USD | -8.02% |
| 2022 Q3 | 1.06 Million USD | 27.51% |
| 2022 FY | 1.01 Million USD | 18.36% |
| 2022 Q2 | 837.44 Thousand USD | -38.93% |
| 2022 Q4 | 1.01 Million USD | -4.71% |
| 2022 Q1 | 1.37 Million USD | 59.51% |
| 2021 Q2 | 867.28 Thousand USD | -35.77% |
| 2021 FY | 859.69 Thousand USD | -3.7% |
| 2021 Q3 | 1.37 Million USD | 59.06% |
| 2021 Q1 | 1.35 Million USD | 51.25% |
| 2021 Q4 | 859.69 Thousand USD | -37.68% |
| 2020 FY | 892.76 Thousand USD | -11.42% |
| 2020 Q2 | 846.28 Thousand USD | -24.92% |
| 2020 Q4 | 892.76 Thousand USD | -14.72% |
| 2020 Q3 | 1.04 Million USD | 23.71% |
| 2020 Q1 | 1.12 Million USD | 11.84% |
| 2019 Q1 | 1.37 Million USD | 8.32% |
| 2019 Q4 | 1 Million USD | -24.05% |
| 2019 Q3 | 1.32 Million USD | 23.74% |
| 2019 Q2 | 1.07 Million USD | -21.85% |
| 2019 FY | 1 Million USD | -20.44% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q3 | 1.45 Million USD | 0.0% |
| 2018 Q4 | 1.26 Million USD | -12.73% |
| 2018 FY | 1.26 Million USD | 42.22% |
| 2017 Q4 | 1.01 Million USD | 0.0% |
| 2017 FY | 890.78 Thousand USD | -48.16% |
| 2016 FY | 1.71 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | 92.066% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 99.272% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 88.037% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 99.224% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 85.88% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 85.88% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | 56.689% |
| Alpha Teknova, Inc. | 11.59 Million USD | 93.016% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 97.495% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | 98.48% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 98.766% |
| Cosmos Health Inc. | 4.78 Million USD | 83.092% |
| PainReform Ltd. | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 99.468% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 93.048% |
| Procaps Group, S.A. | 96.83 Million USD | 99.164% |
| Theratechnologies Inc. | 6.06 Million USD | 86.651% |
| Harrow Health, Inc. | 10.86 Million USD | 92.548% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 70.219% |
| Biofrontera Inc. | 10.9 Million USD | 92.576% |
| DURECT Corporation | 2.21 Million USD | 63.508% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 98.954% |
| Cronos Group Inc. | 30.33 Million USD | 97.331% |
| OptiNose, Inc. | 8.05 Million USD | 89.943% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -80975600.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 85.791% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 97.134% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 69.753% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 82.432% |
| Radius Health, Inc. | 278.64 Million USD | 99.709% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 75.779% |
| ProPhase Labs, Inc. | 3.84 Million USD | 78.918% |
| Phibro Animal Health Corporation | 265.91 Million USD | 99.695% |
| Procaps Group S.A. | 96.83 Million USD | 99.164% |
| Alvotech | 74.43 Million USD | 98.912% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.977% |
| Rockwell Medical, Inc. | 5.87 Million USD | 86.208% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 93.59% |
| SIGA Technologies, Inc. | 64.21 Million USD | 98.739% |
| Tilray Brands, Inc. | 252.08 Million USD | 99.679% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 97.975% |
| Shineco, Inc. | 1.58 Million USD | 49.025% |
| PetIQ, Inc. | 159.3 Million USD | 99.492% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 630.022% |
| Incannex Healthcare Limited | -10.01 Million USD | 108.085% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 97.886% |
| Alimera Sciences, Inc. | 1.87 Million USD | 56.905% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 97.851% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | 49.717% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 81.937% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -218.361% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 92.199% |
| Hempacco Co., Inc. | 2.54 Million USD | 68.153% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 98.912% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 98.306% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 98.735% |
| Currenc Group, Inc. | 732.91 Thousand USD | -10.485% |
| Kamada Ltd. | 87.74 Million USD | 99.077% |
| Indivior PLC | 141.79 Million USD | 99.429% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -68.055% |
| Flora Growth Corp. | 8.5 Million USD | 90.482% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -218.361% |
| Evolus, Inc. | 10.99 Million USD | 92.637% |
| HUTCHMED (China) Limited | 50.25 Million USD | 98.389% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 99.235% |
| Akanda Corp. | 1.28 Million USD | 37.077% |